American Society of Clinical Oncology (ASCO) 2024 ++++

https://www.medscape.com/viewcollection/37458?ecd=mkm_ret_240809_mscpmrk_masters_non-att_etid6727227&uac=148436CN&impID=6727227 Unlocking ASCO 2024: Must-Know Breakthroughs https://www.medscape.com/viewarticle/unlocking-asco-2024-must-know-breakthroughs-2024a1000chj?ecd=mkm_ret_240809_mscpmrk_masters_non-att_etid6727227&uac=148436CN&impID=6727227 'Impressive' 5-Year Progression-Free Survival With Lorlatinib in ALK+ NSCLC https://www.medscape.com/viewarticle/outstanding-5-year-progression-free-survival-lorlatinib-alk-2024a1000aas?ecd=mkm_ret_240809_mscpmrk_masters_non-att_etid6727227&uac=148436CN&impID=6727227 ESOPEC: FLOT Bests CROSS in Resectable Esophageal Cancer https://www.medscape.com/viewarticle/esopec-flot-bests-cross-resectable-esophageal-cancer-2024a1000azn?ecd=mkm_ret_240809_mscpmrk_masters_non-att_etid6727227&uac=148436CN&impID=6727227